Delivery Order SPE2DB20D3103-SPE2DB25FQ0X1
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $40K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ruxience 500 mg/50 ml vials, with a contract ceiling value of $5,381.40. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was not set aside and was competitively awarded through open procurement processes, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ruxience 500 mg/50 mL vials with a contract value of $2,935.32 and a completion date of August 5, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and represents a pharmaceutical supply transaction under the company's existing Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $4,728.70 contract is for the delivery of RUXIENCE 500 MG/50 ML vial medication with an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,028.91 firm fixed price delivery order is for the RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical product. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,913.72 firm fixed-price contract is for the delivery of the medication RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of July 3, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,550.87, is a delivery order for the pharmaceutical product Ruxience 500 mg/50 ml vial with an ultimate completion date of May 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,080.62 firm fixed-price delivery order is for the supply of 500 mg/50 ml vials of the drug RUXIENCE. The contract has an ultimate completion date of January 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a Firm Fixed Price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $8,895.73 and a period of performance through June 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical and pharmaceutical products to federal agencies. This delivery order is not associated with a set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $11,951.84 for RUXIENCE 500 mg/50 ml vials on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. RUXIENCE is a biosimilar to rituximab used in the treatment of various cancers...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $13,571.16 fixed-price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of June 16, 2025. This award is not set-aside and is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...